Cargando…

Atractylenolide III Attenuates Angiogenesis in Gastric Precancerous Lesions Through the Downregulation of Delta-Like Ligand 4

Background: Blocking and even reversing gastric precancerous lesions (GPL) is a key measure to lower the incidence of gastric cancer. Atractylenolide III (AT-III) is a mainly active component of the Atractylodes rhizome and has been widely used in tumor treatment. However, the effects of AT-III on G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Ying, Wang, Jundong, Zhao, Maoyuan, Xia, Ting, Liu, Qingsong, Chen, Nianzhi, Liao, Wenhao, Zeng, Zhongzhen, You, Fengming, Zeng, Jinhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282052/ https://www.ncbi.nlm.nih.gov/pubmed/35846998 http://dx.doi.org/10.3389/fphar.2022.797805

Ejemplares similares

Ginsenoside Rb1 Lessens Gastric Precancerous Lesions by Interfering With β-Catenin/TCF4 Interaction
por: Zeng, Jinhao, et al.
Publicado: (2021)

Weipixiao attenuate early angiogenesis in rats with gastric precancerous lesions
por: Zeng, Jinhao, et al.
Publicado: (2018)

Construction and Validation of Pyroptosis-Related lncRNA Prediction Model for Colon Adenocarcinoma and Immune Infiltration Analysis
por: Liu, Qingsong, et al.
Publicado: (2022)

The Anticancer Effects of Atractylenolide III Associate With the Downregulation of Jak3/Stat3-Dependent IDO Expression
por: Liu, Jun-bao, et al.
Publicado: (2020)

UPLC-MS/MS of Atractylenolide I, Atractylenolide II, Atractylenolide III, and Atractyloside A in Rat Plasma after Oral Administration of Raw and Wheat Bran-Processed Atractylodis Rhizoma
por: Xu, Shizhao, et al.
Publicado: (2018)

Atractylenolide-III suppresses lipopolysaccharide-induced inflammation via downregulation of toll-like receptor 4 in mouse microglia
por: Novianti, Ela, et al.
Publicado: (2021)

Atractylenolide III Improves Mitochondrial Function and Protects Against Ulcerative Colitis by Activating AMPK/SIRT1/PGC-1α
por: Han, Jieru, et al.
Publicado: (2022)

Catalytic approach to in vivo metabolism of atractylenolide III using biomimetic iron–porphyrin complexes
por: Lim, Hanae, et al.
Publicado: (2021)

Atractylenolide III ameliorates spinal cord injury in rats by modulating microglial/macrophage polarization
por: Xue, Meng‐Tong, et al.
Publicado: (2022)

Use of folic acid supplementation to halt and even reverse the progression of gastric precancerous conditions: a meta-analysis
por: Lei, Jing, et al.
Publicado: (2022)

LINC00853 contributes to tumor stemness of gastric cancer through FOXP3-mediated transcription of PDZK1IP1
por: Hu, Xia, et al.
Publicado: (2023)

Atractylenolide III Attenuates Muscle Wasting in Chronic Kidney Disease via the Oxidative Stress-Mediated PI3K/AKT/mTOR Pathway
por: Wang, Mingqing, et al.
Publicado: (2019)

Atractylenolide III Attenuates Apoptosis in H9c2 Cells by Inhibiting Endoplasmic Reticulum Stress through the GRP78/PERK/CHOP Signaling Pathway
por: Zuo, Meng-yu, et al.
Publicado: (2022)

Atractylenolide III inhibits epithelial-mesenchymal transition in small intestine epithelial cells by activating the AMPK signaling pathway
por: Huang, Mingjin, et al.
Publicado: (2022)

Anti-tumor effects of Atractylenolide I on bladder cancer cells
por: Yu, Rui, et al.
Publicado: (2016)

Atractylenolide I inhibits antibiotic-induced dysbiosis of the intestinal microbiome
por: Liu, Penglin, et al.
Publicado: (2021)

Atractylenolide III alleviates sepsis-mediated lung injury via inhibition of FoxO1 and VNN1 protein
por: Fu, Ji-ding, et al.
Publicado: (2021)

Berberine Suppresses Stemness and Tumorigenicity of Colorectal Cancer Stem-Like Cells by Inhibiting m(6)A Methylation
por: Zhao, Ziyi, et al.
Publicado: (2021)

Anti-Tumor Effects of Atractylenolide-I on Human Ovarian Cancer Cells
por: Long, Fangyi, et al.
Publicado: (2017)

Correction to: Anti-tumor effects of Atractylenolide I on bladder cancer cells
por: Yu, Rui, et al.
Publicado: (2018)

Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson’s Disease
por: More, Sandeep, et al.
Publicado: (2017)

Anti-Tumor Activity of Atractylenolide I in Human Colon Adenocarcinoma In Vitro
por: Chan, Ka Woon Karen, et al.
Publicado: (2020)

Chemical Constitution, Pharmacological Effects and the Underlying Mechanism of Atractylenolides: A Review
por: Xie, Zhiyi, et al.
Publicado: (2023)

Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway
por: Li, Qian, et al.
Publicado: (2022)

Atractylenolide III ameliorated reflux esophagitis via PI3K/AKT/NF-κB/iNOS pathway in rats
por: Si, Xianzhe, et al.
Publicado: (2023)

Rediscovery of Traditional Plant Medicine: An Underestimated Anticancer Drug of Chelerythrine
por: Chen, Nianzhi, et al.
Publicado: (2022)

A Randomized Pilot Study of Atractylenolide I on Gastric Cancer Cachexia Patients
por: Liu, Yi, et al.
Publicado: (2008)

Atractylenolide III Ameliorates Bile Duct Ligation-Induced Liver Fibrosis by Inhibiting the PI3K/AKT Pathway and Regulating Glutamine Metabolism
por: Wang, Yan, et al.
Publicado: (2023)

Chemopreventive effects of atractylenolide II on mammary tumorigenesis via activating Nrf2-ARE pathway
por: Wang, Ting, et al.
Publicado: (2017)

Ginsenoside Rg3 induces apoptosis and inhibits proliferation by down-regulating TIGAR in rats with gastric precancerous lesions
por: Lv, Shangbin, et al.
Publicado: (2022)

Quantitative Interrelation between Atractylenolide I, II, and III in Atractylodes japonica Koidzumi Rhizomes, and Evaluation of Their Oxidative Transformation Using a Biomimetic Kinetic Model
por: Kim, Jung-Hoon, et al.
Publicado: (2018)

Correction: Ginsenoside Rg3 induces apoptosis and inhibits proliferation by down-regulating TIGAR in rats with gastric precancerous lesions
por: Lv, Shangbin, et al.
Publicado: (2023)

The Notch ligand Delta-like 4 (DLL4) as a target in angiogenesis-based cancer therapy?
por: Brzozowa, Marlena, et al.
Publicado: (2013)

Establishment of a mouse model of cancer cachexia with spleen deficiency syndrome and the effects of atractylenolide I
por: Zhang, Wan-li, et al.
Publicado: (2019)

Atractylenolide I alleviates ischemia/reperfusion injury by preserving mitochondrial function and inhibiting caspase-3 activity
por: Sun, Caiqin, et al.
Publicado: (2021)

FOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer
por: Li, Xiaoju, et al.
Publicado: (2018)

RNF138 Downregulates Antiviral Innate Immunity by Inhibiting IRF3 Activation
por: Zeng, Xianhuang, et al.
Publicado: (2023)

Helicobacter pylori Eradication Reduces the Metachronous Recurrence of Gastric Neoplasms by Attenuating the Precancerous Process
por: Jung, Da Hyun, et al.
Publicado: (2015)

Anti-Tumor Effects of Atractylenolide I Isolated from Atractylodes macrocephala in Human Lung Carcinoma Cell Lines
por: Liu, Huanyi, et al.
Publicado: (2013)

Atractylenolide-1 alleviates gastroparesis in diabetic rats by activating the stem cell factor/c-kit signaling pathway
por: Li, Hui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_93chpraujoj7dukpj9uebqo4g0